The current situation of cancer morbidity and mortality in the light of the National Cancer Registry, Hungary. Studies on prostatic cancer.
Treatment Methods for Early and Advanced Prostate Cancer
The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res. Treatment strategies for advanced prostate cancer.
Actualities in the medical treatment of metastatic prostate cancer. Novelties in diagnostics and treatment of prostate cancer.
- A prosztata külső gyulladása
- Krónikus prosztatitis idősebb
- Népi gyógyászat kezelése Prostatitis
- One of the treatment options for advanced prostate cancer is androgen deprivation therapy, which uses drugs to lower levels of the hormones that help prostate cancer cells grow.
- Prostatitis abacteriana tratamiento natural
- Но каждый раз, когда он предлагал перевод, дешифровщики в отчаянии качали головами.
- Nyirády, Péter - Google znalac
Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer GETUG-AFU 15 : a randomised, open-label, phase 3 trial. Lancet Oncol.
FDA Approves First Oral Hormone Therapy for Treating Advanced Prostate Cancer
J Clin Oncol. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer.
Urológia Rövid leírás: With an outstanding editorial and contributor team from the world's experts, Treatment Methods for Early and Advanced Prostate Cancer will focus on the "how to treat" scenario faced by urologic surgeons treating all stages of prostate cancer, by examining all the various methods used to treat the condition, both its early and advanced stage. Hosszú leírás: Prostate cancer is treated in a number of different ways, depending on a host of different factors, ranging from the severity of the cancer, the health of the patient, their age, and their own personal choice of treatment.
N Engl J Med. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer STAMPEDE : survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. Lancet ; — Eur Urol.
Ann Oncol. Androgen receptor-mediated processes in castrate-resistant metastatic prostate cancer.
Abiraterone and increased survival in metastatic prostate cancer. Abiraterone in metastatic prostate cancer without previous chemotherapy. Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer.
Abiraterone for prostate cancer not previously treated with hormone therapy. Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol. The evolving landscape of metastatic hormone-sensitive prostate cancer: a critical review of the evidence for adding docetaxel or abiraterone to androgen deprivation.
Prostate Cancer Prostatic Dis.